Enlivex Therapeutics Ltd
Biotechnology
Healthcare
ENLV
21.90 M shares
NASDAQ US
traded
15 Aug 2025
listed
no
open
1.93
52 week high
1.82
high
2.10
52 week low
0.00
previous Close
1.78
P/E ratio
market cap
31.96 M
div yield
0
net profit margin
0.00 %
0.00 %
operating incoming
0.00 %
net change in cash
0.00 %
top